Summary of Study ST001135
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000760. The data can be accessed directly via it's Project DOI: 10.21228/M8FH6C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001135 |
Study Title | Different dose exposure of OPC-163493 on HepG2 cells (part-I) |
Study Type | Compound dosage test |
Study Summary | Metabolomics analysis were on 8 samples of HepG2 cells that were treated with compound OPC-163493 (DMSO control, 1, 3, or 10µM; each n=2) exposure for 30 min. |
Institute | Otsuka Pharmaceutical Co., Ltd. |
Last Name | Kanemoto |
First Name | Naohide |
Address | 463-10 Kagasuno Kawauchi-cho Tokushima 771-0192, Japan |
Kanemoto.Naohide@otsuka.jp | |
Phone | 81-03-6717-1400 |
Submit Date | 2019-02-07 |
Analysis Type Detail | LC-MS |
Release Date | 2019-03-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Combined analysis:
Analysis ID | AN001860 | AN001861 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | CE | CE |
Chromatography system | Agilent 7100 CE | Agilent 7100 CE |
Column | Fused silica capillary, i.d. 50 μm × 80 cm | Fused silica capillary, i.d. 50 μm × 80 cm |
MS Type | ESI | ESI |
MS instrument type | Other | Triple quadrupole |
MS instrument name | Agilent 6210 TOF | Agilent 6460 QQQ |
Ion Mode | UNSPECIFIED | UNSPECIFIED |
Units | Concentration (pmol/1000000 cells) | Concentration (pmol/1000000 cells) |